In fact, improving rates of AS were cited by the US Preventive Services Task Force in its 2018 revision of its prostate cancer screening guideline, with PSA screening now upgraded to a “C,” favoring shared decision-making.19 The gene discussed is KLK3; the disease is Familial prostate cancer.